メラトニンAPIの世界市場規模、シェア、企業ランキング、売上、需要動向予測(2026~2032年)
Melatonin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

- レポートID:143437
- 発表時期:2026-02-01
- レポート形式:PDF
- 産業カテゴリー:化学及び材料
- レポート言語:英語、日本語
- ページ数:140
- 発行会社(調査会社):QYResearch
言語とエディションの価格
- 英語版
- 日本語版
- 英語と日本語版
個人版詳細
マルチユーザー版詳細
企業版詳細
- 英語版
- 日本語版
- 英語と日本語版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=162.40円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
レポートの概要
本報告書は、世界のメラトニンAPI市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からメラトニンAPI市場を分析し、需要構造と成長特性を明確化します。
メラトニンAPI市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、メラトニンAPIに関する的確な意思決定を行うための実践的なインサイトを提供します。
主要メラトニンAPI市場の統計
2025年世界市場規模:114百万米ドル
2026年世界市場規模:122百万米ドル
2032年予測市場規模:196百万米ドル
2026–2032年予測期間CAGR:8.2%
本レポートはメラトニンAPI市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。
【市場セグメンテーション】
主要企業・競争環境
メラトニンAPI市場の主要企業には以下が含まれます:
Merck KGaA
Caesar & Loretz GmbH
EVONIK
Bio-Techne Corp.
Cayman Chemical Company (Matreya)
Spectrum Chemical
Caesar & Loretz GmbH
LGM Pharma
Flavine Europe GmbH
Ralington Pharma
SimSon Pharma Limited
Santa Cruz Biotechnology, Inc.
Biosynth
Otto Chemie Pvt. Ltd.
Pharmaffiliates Analytics and Synthetics P. Ltd.
Clearsynth Labs
製品別
Natural
Synthetic
アプリケーション別
Biotechnology Company
Pharmaceutical Company
Others
レポート対象地域
北米:アメリカ、カナダ、その他
アジア太平洋:中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ:メキシコ、ブラジル、その他
中東・アフリカ:トルコ、サウジアラビア、UAE、その他
レポート構成(章別概要)
第1章|市場概要と成長展望
メラトニンAPI市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章|主要企業の競争分析
メラトニンAPI市場における主要プレイヤー(トップ5社・トップ10社)を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章|製品カテゴリ別市場動向
製品タイプ別にメラトニンAPI市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章|用途別市場動向
用途別にメラトニンAPI市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章|地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、メラトニンAPI市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章|国別市場動向
主要国・地域ごとに、メラトニンAPI市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章|主要企業プロファイル
メラトニンAPI市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章|バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章|調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章|付録(調査手法・データソース)
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します
本レポートの要点と洞察
●メラトニンAPI市場の全体像と成長見通し
メラトニンAPI市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がメラトニンAPI市場に与える影響を分析いたします。
●市場環境の構成要素とマクロトレンド
メラトニンAPI産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します。
●競争構造と主要企業の動向分析
メラトニンAPI市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します。
●競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からメラトニンAPI市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします。
●成長要因・課題・リスクの分析
メラトニンAPI市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します。
●将来トレンドと市場展望
メラトニンAPI市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします。
Description
The global market for Melatonin API was estimated to be worth US$ 114 million in 2025 and is projected to reach US$ 196 million, growing at a CAGR of 8.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Melatonin API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The term "API" in the context of pharmaceuticals stands for Active Pharmaceutical Ingredient. An Active Pharmaceutical Ingredient is the biologically active component of a drug, and it is responsible for its therapeutic effects. Melatonin is a hormone naturally produced in the pineal gland of the brain, and it plays a crucial role in regulating the sleep-wake cycle. When used in the context of pharmaceuticals, "Melatonin API" refers to the active pharmaceutical ingredient of melatonin that is isolated and used as the primary therapeutic agent in medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report provides a comprehensive view of the global market for Melatonin API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Melatonin API market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Melatonin API.
Market Segmentation
By Company
Merck KGaA
Caesar & Loretz GmbH
EVONIK
Bio-Techne Corp.
Cayman Chemical Company (Matreya)
Spectrum Chemical
Caesar & Loretz GmbH
LGM Pharma
Flavine Europe GmbH
Ralington Pharma
SimSon Pharma Limited
Santa Cruz Biotechnology, Inc.
Biosynth
Otto Chemie Pvt. Ltd.
Pharmaffiliates Analytics and Synthetics P. Ltd.
Clearsynth Labs
Segment by Type
Natural
Synthetic
Segment by Application
Biotechnology Company
Pharmaceutical Company
Others
By Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Melatonin API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Melatonin API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Melatonin API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Melatonin API Product Introduction
1.2 Global Melatonin API Market Size Forecast
1.2.1 Global Melatonin API Sales Value (2021–2032)
1.2.2 Global Melatonin API Sales Volume (2021–2032)
1.2.3 Global Melatonin API Sales Price (2021–2032)
1.3 Melatonin API Market Trends & Drivers
1.3.1 Melatonin API Industry Trends
1.3.2 Melatonin API Market Drivers & Opportunities
1.3.3 Melatonin API Market Challenges
1.3.4 Melatonin API Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Melatonin API Players Revenue Ranking (2025)
2.2 Global Melatonin API Revenue by Company (2021–2026)
2.3 Global Melatonin API Sales Volume Ranking of Players (2025)
2.4 Global Melatonin API Sales Volume by Company (2021–2026)
2.5 Global Melatonin API Average Price by Company (2021–2026)
2.6 Key Manufacturers Melatonin API Manufacturing Base and Headquarters
2.7 Key Manufacturers Melatonin API Product Offerings
2.8 Key Manufacturers Start of Mass Production of Melatonin API
2.9 Melatonin API Market Competitive Analysis
2.9.1 Melatonin API Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Melatonin API Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Melatonin API revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Melatonin API Market Classification
3.1 Introduction by Type
3.1.1 Natural
3.1.2 Synthetic
3.1.3 Global Melatonin API Sales Value by Type
3.1.3.1 Global Melatonin API Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Melatonin API Sales Value, by Type (2021–2032)
3.1.3.3 Global Melatonin API Sales Value, by Type (%), 2021–2032
3.1.4 Global Melatonin API Sales Volume by Type
3.1.4.1 Global Melatonin API Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Melatonin API Sales Volume, by Type (2021–2032)
3.1.4.3 Global Melatonin API Sales Volume, by Type (%), 2021–2032
3.1.5 Global Melatonin API Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology Company
4.1.2 Pharmaceutical Company
4.1.3 Others
4.2 Global Melatonin API Sales Value by Application
4.2.1 Global Melatonin API Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Melatonin API Sales Value, by Application (2021–2032)
4.2.3 Global Melatonin API Sales Value, by Application (%), 2021–2032
4.3 Global Melatonin API Sales Volume by Application
4.3.1 Global Melatonin API Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Melatonin API Sales Volume, by Application (2021–2032)
4.3.3 Global Melatonin API Sales Volume, by Application (%), 2021–2032
4.4 Global Melatonin API Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Melatonin API Sales Value by Region
5.1.1 Global Melatonin API Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Melatonin API Sales Value by Region (2021–2026)
5.1.3 Global Melatonin API Sales Value by Region (2027–2032)
5.1.4 Global Melatonin API Sales Value by Region (%), 2021–2032
5.2 Global Melatonin API Sales Volume by Region
5.2.1 Global Melatonin API Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Melatonin API Sales Volume by Region (2021–2026)
5.2.3 Global Melatonin API Sales Volume by Region (2027–2032)
5.2.4 Global Melatonin API Sales Volume by Region (%), 2021–2032
5.3 Global Melatonin API Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Melatonin API Sales Value, 2021–2032
5.4.2 North America Melatonin API Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Melatonin API Sales Value, 2021–2032
5.5.2 Europe Melatonin API Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Melatonin API Sales Value, 2021–2032
5.6.2 Asia Pacific Melatonin API Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Melatonin API Sales Value, 2021–2032
5.7.2 South America Melatonin API Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Melatonin API Sales Value, 2021–2032
5.8.2 Middle East & Africa Melatonin API Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Melatonin API Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Melatonin API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Melatonin API Sales Value, 2021–2032
6.2.2 Key Countries/Regions Melatonin API Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Melatonin API Sales Value, 2021–2032
6.3.2 United States Melatonin API Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Melatonin API Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Melatonin API Sales Value, 2021–2032
6.4.2 Europe Melatonin API Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Melatonin API Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Melatonin API Sales Value, 2021–2032
6.5.2 China Melatonin API Sales Value by Type (%), 2025 vs 2032
6.5.3 China Melatonin API Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Melatonin API Sales Value, 2021–2032
6.6.2 Japan Melatonin API Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Melatonin API Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Melatonin API Sales Value, 2021–2032
6.7.2 South Korea Melatonin API Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Melatonin API Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Melatonin API Sales Value, 2021–2032
6.8.2 Southeast Asia Melatonin API Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Melatonin API Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Melatonin API Sales Value, 2021–2032
6.9.2 India Melatonin API Sales Value by Type (%), 2025 vs 2032
6.9.3 India Melatonin API Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Company Information
7.1.2 Merck KGaA Introduction and Business Overview
7.1.3 Merck KGaA Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Merck KGaA Melatonin API Product Offerings
7.1.5 Merck KGaA Recent Developments
7.2 Caesar & Loretz GmbH
7.2.1 Caesar & Loretz GmbH Company Information
7.2.2 Caesar & Loretz GmbH Introduction and Business Overview
7.2.3 Caesar & Loretz GmbH Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Caesar & Loretz GmbH Melatonin API Product Offerings
7.2.5 Caesar & Loretz GmbH Recent Developments
7.3 EVONIK
7.3.1 EVONIK Company Information
7.3.2 EVONIK Introduction and Business Overview
7.3.3 EVONIK Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 EVONIK Melatonin API Product Offerings
7.3.5 EVONIK Recent Developments
7.4 Bio-Techne Corp.
7.4.1 Bio-Techne Corp. Company Information
7.4.2 Bio-Techne Corp. Introduction and Business Overview
7.4.3 Bio-Techne Corp. Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Bio-Techne Corp. Melatonin API Product Offerings
7.4.5 Bio-Techne Corp. Recent Developments
7.5 Cayman Chemical Company (Matreya)
7.5.1 Cayman Chemical Company (Matreya) Company Information
7.5.2 Cayman Chemical Company (Matreya) Introduction and Business Overview
7.5.3 Cayman Chemical Company (Matreya) Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Cayman Chemical Company (Matreya) Melatonin API Product Offerings
7.5.5 Cayman Chemical Company (Matreya) Recent Developments
7.6 Spectrum Chemical
7.6.1 Spectrum Chemical Company Information
7.6.2 Spectrum Chemical Introduction and Business Overview
7.6.3 Spectrum Chemical Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Spectrum Chemical Melatonin API Product Offerings
7.6.5 Spectrum Chemical Recent Developments
7.7 Caesar & Loretz GmbH
7.7.1 Caesar & Loretz GmbH Company Information
7.7.2 Caesar & Loretz GmbH Introduction and Business Overview
7.7.3 Caesar & Loretz GmbH Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Caesar & Loretz GmbH Melatonin API Product Offerings
7.7.5 Caesar & Loretz GmbH Recent Developments
7.8 LGM Pharma
7.8.1 LGM Pharma Company Information
7.8.2 LGM Pharma Introduction and Business Overview
7.8.3 LGM Pharma Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 LGM Pharma Melatonin API Product Offerings
7.8.5 LGM Pharma Recent Developments
7.9 Flavine Europe GmbH
7.9.1 Flavine Europe GmbH Company Information
7.9.2 Flavine Europe GmbH Introduction and Business Overview
7.9.3 Flavine Europe GmbH Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Flavine Europe GmbH Melatonin API Product Offerings
7.9.5 Flavine Europe GmbH Recent Developments
7.10 Ralington Pharma
7.10.1 Ralington Pharma Company Information
7.10.2 Ralington Pharma Introduction and Business Overview
7.10.3 Ralington Pharma Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Ralington Pharma Melatonin API Product Offerings
7.10.5 Ralington Pharma Recent Developments
7.11 SimSon Pharma Limited
7.11.1 SimSon Pharma Limited Company Information
7.11.2 SimSon Pharma Limited Introduction and Business Overview
7.11.3 SimSon Pharma Limited Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 SimSon Pharma Limited Melatonin API Product Offerings
7.11.5 SimSon Pharma Limited Recent Developments
7.12 Santa Cruz Biotechnology, Inc.
7.12.1 Santa Cruz Biotechnology, Inc. Company Information
7.12.2 Santa Cruz Biotechnology, Inc. Introduction and Business Overview
7.12.3 Santa Cruz Biotechnology, Inc. Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Santa Cruz Biotechnology, Inc. Melatonin API Product Offerings
7.12.5 Santa Cruz Biotechnology, Inc. Recent Developments
7.13 Biosynth
7.13.1 Biosynth Company Information
7.13.2 Biosynth Introduction and Business Overview
7.13.3 Biosynth Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Biosynth Melatonin API Product Offerings
7.13.5 Biosynth Recent Developments
7.14 Otto Chemie Pvt. Ltd.
7.14.1 Otto Chemie Pvt. Ltd. Company Information
7.14.2 Otto Chemie Pvt. Ltd. Introduction and Business Overview
7.14.3 Otto Chemie Pvt. Ltd. Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Otto Chemie Pvt. Ltd. Melatonin API Product Offerings
7.14.5 Otto Chemie Pvt. Ltd. Recent Developments
7.15 Pharmaffiliates Analytics and Synthetics P. Ltd.
7.15.1 Pharmaffiliates Analytics and Synthetics P. Ltd. Company Information
7.15.2 Pharmaffiliates Analytics and Synthetics P. Ltd. Introduction and Business Overview
7.15.3 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Product Offerings
7.15.5 Pharmaffiliates Analytics and Synthetics P. Ltd. Recent Developments
7.16 Clearsynth Labs
7.16.1 Clearsynth Labs Company Information
7.16.2 Clearsynth Labs Introduction and Business Overview
7.16.3 Clearsynth Labs Melatonin API Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Clearsynth Labs Melatonin API Product Offerings
7.16.5 Clearsynth Labs Recent Developments
8 Industry Chain Analysis
8.1 Melatonin API Industrial Chain
8.2 Melatonin API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Melatonin API Sales Model
8.5.2 Sales Channels
8.5.3 Melatonin API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables Table 1. Melatonin API Market Trends Table 2. Melatonin API Market Drivers & Opportunities Table 3. Melatonin API Market Challenges Table 4. Melatonin API Market Restraints Table 5. Global Melatonin API Revenue by Company (US$ Million), 2021–2026 Table 6. Global Melatonin API Revenue Market Share by Company (2021–2026) Table 7. Global Melatonin API Sales Volume by Company (Tons), 2021–2026 Table 8. Global Melatonin API Sales Volume Market Share by Company (2021–2026) Table 9. Global Market Melatonin API Price by Company (US$/Ton), 2021–2026 Table 10. Key Manufacturers Melatonin API Manufacturing Base and Headquarters Table 11. Key Manufacturers Melatonin API Product Type Table 12. Key Manufacturers Start of Mass Production of Melatonin API Table 13. Global Melatonin API Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Melatonin API revenue, 2025 Table 15. Mergers & Acquisitions and Expansion Plans Table 16. Global Melatonin API Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million) Table 17. Global Melatonin API Sales Value by Type (US$ Million), 2021–2026 Table 18. Global Melatonin API Sales Value by Type (US$ Million), 2027–2032 Table 19. Global Melatonin API Sales Market Share in Value by Type (2021–2026) Table 20. Global Melatonin API Sales Market Share in Value by Type (2027–2032) Table 21. Global Melatonin API Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons) Table 22. Global Melatonin API Sales Volume by Type (Tons), 2021–2026 Table 23. Global Melatonin API Sales Volume by Type (Tons), 2027–2032 Table 24. Global Melatonin API Sales Market Share in Volume by Type (2021–2026) Table 25. Global Melatonin API Sales Market Share in Volume by Type (2027–2032) Table 26. Global Melatonin API Price by Type (US$/Ton), 2021–2026 Table 27. Global Melatonin API Price by Type (US$/Ton), 2027–2032 Table 28. Global Melatonin API Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million) Table 29. Global Melatonin API Sales Value by Application (US$ Million), 2021–2026 Table 30. Global Melatonin API Sales Value by Application (US$ Million), 2027–2032 Table 31. Global Melatonin API Sales Market Share in Value by Application (2021–2026) Table 32. Global Melatonin API Sales Market Share in Value by Application (2027–2032) Table 33. Global Melatonin API Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons) Table 34. Global Melatonin API Sales Volume by Application (Tons), 2021–2026 Table 35. Global Melatonin API Sales Volume by Application (Tons), 2027–2032 Table 36. Global Melatonin API Sales Market Share in Volume by Application (2021–2026) Table 37. Global Melatonin API Sales Market Share in Volume by Application (2027–2032) Table 38. Global Melatonin API Price by Application (US$/Ton), 2021–2026 Table 39. Global Melatonin API Price by Application (US$/Ton), 2027–2032 Table 40. Global Melatonin API Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032 Table 41. Global Melatonin API Sales Value by Region (US$ Million), 2021–2026 Table 42. Global Melatonin API Sales Value by Region (US$ Million), 2027–2032 Table 43. Global Melatonin API Sales Value by Region (%), 2021–2026 Table 44. Global Melatonin API Sales Value by Region (%), 2027–2032 Table 45. Global Melatonin API Sales Volume by Region (Tons): 2021 vs 2025 vs 2032 Table 46. Global Melatonin API Sales Volume by Region (Tons), 2021–2026 Table 47. Global Melatonin API Sales Volume by Region (Tons), 2027–2032 Table 48. Global Melatonin API Sales Volume by Region (%), 2021–2026 Table 49. Global Melatonin API Sales Volume by Region (%), 2027–2032 Table 50. Global Melatonin API Average Price by Region (US$/Ton), 2021–2026 Table 51. Global Melatonin API Average Price by Region (US$/Ton), 2027–2032 Table 52. Key Countries/Regions Melatonin API Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032 Table 53. Key Countries/Regions Melatonin API Sales Value, (US$ Million), 2021–2026 Table 54. Key Countries/Regions Melatonin API Sales Value, (US$ Million), 2027–2032 Table 55. Key Countries/Regions Melatonin API Sales Volume, (Tons), 2021–2026 Table 56. Key Countries/Regions Melatonin API Sales Volume, (Tons), 2027–2032 Table 57. Merck KGaA Company Information Table 58. Merck KGaA Introduction and Business Overview Table 59. Merck KGaA Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 60. Merck KGaA Melatonin API Product Offerings Table 61. Merck KGaA Recent Developments Table 62. Caesar & Loretz GmbH Company Information Table 63. Caesar & Loretz GmbH Introduction and Business Overview Table 64. Caesar & Loretz GmbH Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 65. Caesar & Loretz GmbH Melatonin API Product Offerings Table 66. Caesar & Loretz GmbH Recent Developments Table 67. EVONIK Company Information Table 68. EVONIK Introduction and Business Overview Table 69. EVONIK Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 70. EVONIK Melatonin API Product Offerings Table 71. EVONIK Recent Developments Table 72. Bio-Techne Corp. Company Information Table 73. Bio-Techne Corp. Introduction and Business Overview Table 74. Bio-Techne Corp. Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 75. Bio-Techne Corp. Melatonin API Product Offerings Table 76. Bio-Techne Corp. Recent Developments Table 77. Cayman Chemical Company (Matreya) Company Information Table 78. Cayman Chemical Company (Matreya) Introduction and Business Overview Table 79. Cayman Chemical Company (Matreya) Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 80. Cayman Chemical Company (Matreya) Melatonin API Product Offerings Table 81. Cayman Chemical Company (Matreya) Recent Developments Table 82. Spectrum Chemical Company Information Table 83. Spectrum Chemical Introduction and Business Overview Table 84. Spectrum Chemical Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 85. Spectrum Chemical Melatonin API Product Offerings Table 86. Spectrum Chemical Recent Developments Table 87. Caesar & Loretz GmbH Company Information Table 88. Caesar & Loretz GmbH Introduction and Business Overview Table 89. Caesar & Loretz GmbH Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 90. Caesar & Loretz GmbH Melatonin API Product Offerings Table 91. Caesar & Loretz GmbH Recent Developments Table 92. LGM Pharma Company Information Table 93. LGM Pharma Introduction and Business Overview Table 94. LGM Pharma Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 95. LGM Pharma Melatonin API Product Offerings Table 96. LGM Pharma Recent Developments Table 97. Flavine Europe GmbH Company Information Table 98. Flavine Europe GmbH Introduction and Business Overview Table 99. Flavine Europe GmbH Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 100. Flavine Europe GmbH Melatonin API Product Offerings Table 101. Flavine Europe GmbH Recent Developments Table 102. Ralington Pharma Company Information Table 103. Ralington Pharma Introduction and Business Overview Table 104. Ralington Pharma Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 105. Ralington Pharma Melatonin API Product Offerings Table 106. Ralington Pharma Recent Developments Table 107. SimSon Pharma Limited Company Information Table 108. SimSon Pharma Limited Introduction and Business Overview Table 109. SimSon Pharma Limited Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 110. SimSon Pharma Limited Melatonin API Product Offerings Table 111. SimSon Pharma Limited Recent Developments Table 112. Santa Cruz Biotechnology, Inc. Company Information Table 113. Santa Cruz Biotechnology, Inc. Introduction and Business Overview Table 114. Santa Cruz Biotechnology, Inc. Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 115. Santa Cruz Biotechnology, Inc. Melatonin API Product Offerings Table 116. Santa Cruz Biotechnology, Inc. Recent Developments Table 117. Biosynth Company Information Table 118. Biosynth Introduction and Business Overview Table 119. Biosynth Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 120. Biosynth Melatonin API Product Offerings Table 121. Biosynth Recent Developments Table 122. Otto Chemie Pvt. Ltd. Company Information Table 123. Otto Chemie Pvt. Ltd. Introduction and Business Overview Table 124. Otto Chemie Pvt. Ltd. Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 125. Otto Chemie Pvt. Ltd. Melatonin API Product Offerings Table 126. Otto Chemie Pvt. Ltd. Recent Developments Table 127. Pharmaffiliates Analytics and Synthetics P. Ltd. Company Information Table 128. Pharmaffiliates Analytics and Synthetics P. Ltd. Introduction and Business Overview Table 129. Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 130. Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Product Offerings Table 131. Pharmaffiliates Analytics and Synthetics P. Ltd. Recent Developments Table 132. Clearsynth Labs Company Information Table 133. Clearsynth Labs Introduction and Business Overview Table 134. Clearsynth Labs Melatonin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026) Table 135. Clearsynth Labs Melatonin API Product Offerings Table 136. Clearsynth Labs Recent Developments Table 137. Key Raw Materials Lists Table 138. Key Suppliers of Raw Materials Lists Table 139. Melatonin API Downstream Customers Table 140. Melatonin API Distributors List Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Melatonin API Product Picture Figure 2. Global Melatonin API Sales Value, 2021 vs 2025 vs 2032 (US$ Million) Figure 3. Global Melatonin API Sales Value (US$ Million), 2021–2032 Figure 4. Global Melatonin API Sales Volume (Tons), 2021–2032 Figure 5. Global Melatonin API Sales Price (US$/Ton), 2021–2032 Figure 6. Melatonin API Report Years Considered Figure 7. Global Melatonin API Players Revenue Ranking (US$ Million), 2025 Figure 8. Global Melatonin API Sales Volume Ranking of Players (Tons), 2025 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Melatonin API Revenue in 2025 Figure 10. Melatonin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025 Figure 11. Natural Picture Figure 12. Synthetic Picture Figure 13. Global Melatonin API Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032 Figure 14. Global Melatonin API Sales Value Market Share by Type, 2025 & 2032 Figure 15. Global Melatonin API Sales Volume by Type (Tons), 2021 vs 2025 vs 2032 Figure 16. Global Melatonin API Sales Volume Market Share by Type, 2025 & 2032 Figure 17. Global Melatonin API Price by Type (US$/Ton), 2021–2032 Figure 18. Product Picture of Biotechnology Company Figure 19. Product Picture of Pharmaceutical Company Figure 20. Product Picture of Others Figure 21. Global Melatonin API Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032 Figure 22. Global Melatonin API Sales Value Market Share by Application, 2025 & 2032 Figure 23. Global Melatonin API Sales Volume by Application (Tons), 2021 vs 2025 vs 2032 Figure 24. Global Melatonin API Sales Volume Market Share by Application, 2025 & 2032 Figure 25. Global Melatonin API Price by Application (US$/Ton), 2021–2032 Figure 26. North America Melatonin API Sales Value (US$ Million), 2021–2032 Figure 27. North America Melatonin API Sales Value by Country (%), 2025 vs 2032 Figure 28. Europe Melatonin API Sales Value (US$ Million), 2021–2032 Figure 29. Europe Melatonin API Sales Value by Country (%), 2025 vs 2032 Figure 30. Asia Pacific Melatonin API Sales Value (US$ Million), 2021–2032 Figure 31. Asia Pacific Melatonin API Sales Value by Region (%), 2025 vs 2032 Figure 32. South America Melatonin API Sales Value (US$ Million), 2021–2032 Figure 33. South America Melatonin API Sales Value by Country (%), 2025 vs 2032 Figure 34. Middle East & Africa Melatonin API Sales Value (US$ Million), 2021–2032 Figure 35. Middle East & Africa Melatonin API Sales Value by Country (%), 2025 vs 2032 Figure 36. Key Countries/Regions Melatonin API Sales Value (%), 2021–2032 Figure 37. Key Countries/Regions Melatonin API Sales Volume (%), 2021–2032 Figure 38. United States Melatonin API Sales Value (US$ Million), 2021–2032 Figure 39. United States Melatonin API Sales Value by Type (%), 2025 vs 2032 Figure 40. United States Melatonin API Sales Value by Application (%), 2025 vs 2032 Figure 41. Europe Melatonin API Sales Value (US$ Million), 2021–2032 Figure 42. Europe Melatonin API Sales Value by Type (%), 2025 vs 2032 Figure 43. Europe Melatonin API Sales Value by Application (%), 2025 vs 2032 Figure 44. China Melatonin API Sales Value (US$ Million), 2021–2032 Figure 45. China Melatonin API Sales Value by Type (%), 2025 vs 2032 Figure 46. China Melatonin API Sales Value by Application (%), 2025 vs 2032 Figure 47. Japan Melatonin API Sales Value (US$ Million), 2021–2032 Figure 48. Japan Melatonin API Sales Value by Type (%), 2025 vs 2032 Figure 49. Japan Melatonin API Sales Value by Application (%), 2025 vs 2032 Figure 50. South Korea Melatonin API Sales Value (US$ Million), 2021–2032 Figure 51. South Korea Melatonin API Sales Value by Type (%), 2025 vs 2032 Figure 52. South Korea Melatonin API Sales Value by Application (%), 2025 vs 2032 Figure 53. Southeast Asia Melatonin API Sales Value (US$ Million), 2021–2032 Figure 54. Southeast Asia Melatonin API Sales Value by Type (%), 2025 vs 2032 Figure 55. Southeast Asia Melatonin API Sales Value by Application (%), 2025 vs 2032 Figure 56. India Melatonin API Sales Value (US$ Million), 2021–2032 Figure 57. India Melatonin API Sales Value by Type (%), 2025 vs 2032 Figure 58. India Melatonin API Sales Value by Application (%), 2025 vs 2032 Figure 59. Melatonin API Industrial Chain Figure 60. Melatonin API Manufacturing Cost Structure Figure 61. Channels of Distribution (Direct Sales, and Distribution) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed
お見積>
サンプルお申込み>
今すぐ購入>
PDFダウンロード>






